Clinical Trial Update: The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of portal venous supply control with immunotherapy for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN